USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 131 filers reported holding USANA HEALTH SCIENCES INC in Q2 2013. The put-call ratio across all filers is 15.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,473,800 | -5.1% | 46,500 | 0.0% | 0.51% | -10.8% |
Q3 2022 | $2,606,000 | -22.6% | 46,500 | 0.0% | 0.58% | -1.0% |
Q2 2022 | $3,365,000 | -19.9% | 46,500 | +12.0% | 0.58% | -5.4% |
Q4 2021 | $4,200,000 | +9.8% | 41,500 | 0.0% | 0.62% | +12.6% |
Q3 2021 | $3,826,000 | -10.0% | 41,500 | 0.0% | 0.55% | -1.6% |
Q2 2021 | $4,251,000 | +5.0% | 41,500 | 0.0% | 0.56% | +7.4% |
Q1 2021 | $4,050,000 | +40.1% | 41,500 | +10.7% | 0.52% | +26.7% |
Q4 2020 | $2,891,000 | +4.7% | 37,500 | 0.0% | 0.41% | -9.7% |
Q3 2020 | $2,762,000 | +0.3% | 37,500 | 0.0% | 0.45% | -6.2% |
Q2 2020 | $2,754,000 | +27.1% | 37,500 | 0.0% | 0.48% | +9.3% |
Q1 2020 | $2,166,000 | -26.5% | 37,500 | 0.0% | 0.44% | -2.2% |
Q4 2019 | $2,946,000 | +14.9% | 37,500 | 0.0% | 0.45% | +6.6% |
Q3 2019 | $2,565,000 | -13.9% | 37,500 | 0.0% | 0.42% | -11.1% |
Q2 2019 | $2,979,000 | -21.5% | 37,500 | -15.2% | 0.48% | -21.6% |
Q1 2018 | $3,797,000 | +16.0% | 44,200 | 0.0% | 0.61% | +12.2% |
Q4 2017 | $3,273,000 | +28.4% | 44,200 | 0.0% | 0.54% | +27.9% |
Q3 2017 | $2,550,000 | -0.5% | 44,200 | +10.5% | 0.42% | -4.1% |
Q2 2017 | $2,564,000 | +11.3% | 40,000 | 0.0% | 0.44% | +24.2% |
Q1 2017 | $2,304,000 | -5.9% | 40,000 | 0.0% | 0.36% | -13.8% |
Q4 2016 | $2,448,000 | -11.5% | 40,000 | +100.0% | 0.41% | -23.0% |
Q3 2016 | $2,767,000 | +24.1% | 20,000 | 0.0% | 0.54% | +21.0% |
Q2 2016 | $2,229,000 | -27.7% | 20,000 | -28.0% | 0.44% | -11.4% |
Q1 2015 | $3,085,000 | +26.6% | 27,759 | +16.8% | 0.50% | +36.7% |
Q4 2014 | $2,437,000 | +6.5% | 23,759 | -23.5% | 0.36% | 0.0% |
Q3 2014 | $2,288,000 | -5.7% | 31,059 | 0.0% | 0.36% | +5.5% |
Q2 2014 | $2,427,000 | -8.1% | 31,059 | -11.4% | 0.35% | -12.6% |
Q1 2014 | $2,641,000 | +9.0% | 35,059 | +9.4% | 0.40% | +15.1% |
Q4 2013 | $2,423,000 | -12.9% | 32,059 | 0.0% | 0.34% | -18.5% |
Q3 2013 | $2,782,000 | +19.9% | 32,059 | 0.0% | 0.42% | +5.5% |
Q2 2013 | $2,320,000 | – | 32,059 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |